Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tumor necrosis factor ligand superfamily member 13B inhibitor DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lupus Nephritis 4 D008181 ClinicalTrials
Vasculitis 3 D014657 ClinicalTrials
Sjogren's Syndrome 2 D012859 ClinicalTrials
Purpura, Thrombocytopenic, Idiopathic 2 D016553 ClinicalTrials
Myositis 2 D009220 ClinicalTrials
Kidney Diseases 2 D007674 ClinicalTrials
Emphysema 2 D004646 ClinicalTrials
Multiple Sclerosis 2 D009103 ClinicalTrials
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Scleroderma, Systemic 2 D012595 ClinicalTrials
Glomerulonephritis, Membranous 2 D015433 ClinicalTrials
Graft vs Host Disease 1 D006086 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1789843
FDA SRS 73B0K5S26A